Table of Content


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing prevalence of breast cancer worldwide is expected to drive market growth.
4.1.2. Restraints:
4.1.2.1. The high cost of breast surgical procedures is expected to hamper the market growth.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces
5.2. Supply Chain
5.3. Pricing Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Implants*
7.2.1.1. Saline Implants
7.2.1.2. Introduction
7.2.1.3. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.2.1.4. Silicone Implants
7.3. Tissue Expander
7.4. Acellular Dermal Matrix
8. By Shape
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
8.1.2. Market Attractiveness Index, By Shape
8.2. Round Shape*
8.2.1.1. Introduction
8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Anatomical Shape
9. By Placement
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
9.1.2. Market Attractiveness Index, By Placement
9.2. Dual Plane Insertion*
9.2.1.1. Introduction
9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Subglandular Insertion
9.4. Submuscular Insertion
10. By End user
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.1.2. Market Attractiveness Index, By End user
10.2. Hospitals*
10.2.1.1. Introduction
10.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Ambulatory Surgical Centers
10.4. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Shape
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Placement
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Allergan Plc*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Sientra, Inc
13.3. IDEAL IMPLANT INCORPORATED
13.4. Johnson & Johnson
13.5. Establishment Labs S.A.
13.6. GC Aesthetics
13.7. Groupe Sebbin SAS
13.8. Ideal Implant Incorporated
13.9. Laboratoires Arion
13.10. Mentor Worldwide LLC
LIST NOT EXHAUSTIVE
14. Global Breast Reconstruction Market– DataM
14.1. Appendix
14.2. About Us and Applications
14.3. Contact Us